VALN Stock Analysis: Buy, Sell, or Hold?

VALN - Valneva SE American Depositary Shares

Biological Products, (No Diagnostic Substances)
$5.40
0.05 (0.93%) ▲
5d: +0.19%
30d: -8.01%
90d: -16.8%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026

Get Alerted When VALN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: VALN trading at deep discount. Market pricing in -6.3% annual earnings decline, creating value opportunity for patient investors.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$9.18
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.70
5.3% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.3x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: VALN is currently trading at $5.40, which is considered slightly low relative to its 30-day fair value range of $5.31 to $5.98. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.2) compared to its historical average (6.3). Remarkably, the market is currently pricing in an annual earnings decline of 6.3% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, VALN is in a strong downtrend. The price is approaching resistance at $5.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.20 (+125.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $5.31 - $5.98
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 125.9% below Wall St target ($12.20)

Trading Range Analysis

30-Day Trading Range $5.31 - $5.98
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $5.13
Resistance Level $5.50
Current Trend Strong Downtrend
Technical data as of Jun 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) 5.19
Wall Street Target $12.20 (+125.9%)
Revenue Growth (YoY) -37.2%
Profit Margin -88.3%
Valuation Discount vs History -6.3% cheaper
PE vs Historical 5.2 vs 6.3 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -6.3% (market-implied from PE analysis)
1-Year Target $5.06 (-6%)
2-Year Target $4.74 (-12%)
3-Year Target $4.44 (-18%)
3-Yr Target (if PE normalizes) (PE: 5→6) $5.39 (0%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.2 to 6.3
Stabilization Target: $6.55 (+21.3%)
PE Expansion Potential: +21.3%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 24, 2026 2:32 AM ET
Data refreshes hourly during market hours. Next update: 3:32 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VALN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$27 56 HOLD
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 57 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1022 67 BUY
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 61 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD

More Analysis for VALN

VALN Technical Chart VALN Price Prediction VALN Earnings Date VALN Investment Advisor VALN Fair Price Analyzer VALN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals